Duke University Names New Director for MURDOCK Study

Welcome, Julie Eckstrand

Julie Eckstrand, R.Ph., has been named director of operations for the MURDOCK Study and Duke University’s other clinical research studies based at the North Carolina Research Campus (NCRC).

A clinical pharmacist by training, Eckstrand will manage operations for the Translational Population Health Research Group, part of the new Duke Clinical & Translational Science Institute (CTSI). The TransPop group’s research portfolio includes the MURDOCK Study and related projects involving biomarkers, longitudinal registries, and community-engaged research based at the Kannapolis office.

Eckstrand has offices in both Kannapolis and Durham and oversees a team of nearly 30 Duke employees.

“I am thrilled to return to my Duke family and begin new research endeavors with the NCRC community. We have important work to do that has the potential to be enormously impactful,” she said. “I am looking forward to meeting new collaborators and to a bright and productive future.”

Eckstrand has worked almost exclusively in human clinical research for 30 years. Most recently, she was executive director of the Nutrition Science Initiative, a nonprofit medical research organization dedicated to reducing the social and economic costs of obesity, diabetes, and other related and rare diseases by improving the quality of science in nutrition research.

Eckstrand returns to Duke after serving as assistant director for Clinical Support Services and Quality Management at the Duke Clinical Research Unit from 2011 to 2015. Prior to that, she worked as a clinical pharmacist in informatics specializing in enterprise analytics and patient safety research from 2006 to 2011.

A self-described “soccer mom, musician, and Sudoku fanatic,” Eckstrand is married and has two children in high school.

MURDOCK study and more